Collate
Platform that use AI to create and streamline paperwork for diagnostic, medical device, and drug development companies.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $30.0m Valuation: $100m | Seed | |
| Total Funding | 000k | ||
Related Content
An AI-powered platform designed to automate and streamline the creation of documentation for drug development, medical device, and diagnostic companies. The company's mission is to expedite the delivery of life-saving innovations to patients by reducing the time and resources spent on paperwork and document editing. By handling the labor-intensive documentation process, from concept to market, it allows life sciences companies to focus on innovation and discovery. The platform is aimed at a variety of data practitioners and is built to manage and ensure high-quality data assets.
Collate has secured $30 million in a seed funding round, which will support its growth and the development of its AI-powered solutions. The company's services are targeted at the life sciences industry, and it operates within the healthcare technology market, providing a unified platform for data discovery, observability, and governance.
Keywords: AI in healthcare, life sciences, documentation automation, medical devices, drug development, diagnostics, data governance, data discovery, regulatory compliance, healthcare technology